NCT04258280 Improving Genetic Counseling for BRCA+ Mothers
| NCT ID | NCT04258280 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Georgetown University |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2020-07-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2020-07-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Genetic counseling and testing for hereditary breast cancer may reveal that you, and possibly your blood relatives, are at increased risk for the disease across the lifespan. This includes biological children, both male and female. We do not yet know the best ways to educate mothers who have a risk gene (are BRCA+) about whether, when, and how to share genetic information with their children or manage their thoughts and feelings. The purpose of this study is to help mothers make more informed choices about talking with children about hereditary breast cancer, provide them with age-and gender-appropriate information and emotional support, and improve their psychological well-being.
Eligibility Criteria
Inclusion Criteria: * Mothers/primary caregivers to adolescents/young adults ages 13-24 years-old. * Participating in genetic testing for hereditary breast cancer. * Adequately speak/read English. Exclusion Criteria: \- Does not meet inclusion criteria.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04258280 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04258280 currently recruiting?
Yes, NCT04258280 is actively recruiting participants. Contact the research team at familycom@georgetown.edu for enrollment information.
Where is the NCT04258280 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT04258280 clinical trial?
NCT04258280 is sponsored by Georgetown University. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.